Contract manufacturer

Keytronic Selected as a Top 10 Contract Manufacturing Service Provider for 2020

Retrieved on: 
Tuesday, July 14, 2020
Manufacturing, Outsourcing, Contract manufacturer

SPOKANE VALLEY, Wash., July 14, 2020 (GLOBE NEWSWIRE) -- Keytronic Corporation (Nasdaq KTCC), a world class provider of engineering design and electromechanical manufacturing services, today announced it has been selected by Manufacturing Technology Insights Magazine as a Top 10 Contract Manufacturing Service Provider for 2020.

Key Points: 
  • SPOKANE VALLEY, Wash., July 14, 2020 (GLOBE NEWSWIRE) -- Keytronic Corporation (Nasdaq KTCC), a world class provider of engineering design and electromechanical manufacturing services, today announced it has been selected by Manufacturing Technology Insights Magazine as a Top 10 Contract Manufacturing Service Provider for 2020.
  • Im very proud and excited to be selected as a 2020 Top 10 Contract Manufacturing Service Provider, said Craig Gates, President and Chief Executive Officer.
  • This award is validation of many years of hard work transitioning from an OEM manufacturer to a turnkey contract manufacturer.
  • Keytronic is a leading contract manufacturer offering value-added design and manufacturing services from its facilities in the United States, Mexico, China and Vietnam.

Peptide Therapeutics: Contract API Manufacturing Market Outlook, 2030

Retrieved on: 
Friday, July 10, 2020
Peptides, Contract manufacturing organization, Pharmaceutical industry, Contract manufacturer, C-peptide

DUBLIN, July 10, 2020 /PRNewswire/ -- The "Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 10, 2020 /PRNewswire/ -- The "Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • This report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.
  • One of the key objectives of the report was to estimate the existing market size and the future growth potential within the peptide contract manufacturing market.
  • Presently, there are a number of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that offer elaborate portfolios of services focused on peptide design, manufacturing and purification.

Electronic Manufacturing Service Providers DataED and Bestronics Merge to Launch Emerald EMS

Retrieved on: 
Tuesday, June 30, 2020
Contract manufacturer, Outsourcing, Manufacturing, EMS, Economic sectors, Economy

Emerald EMS is a high-tech contract manufacturing and design firm with global, cost-effective, and high value manufacturing solutions servicing high-reliability end users in the industrial controls, semiconductor, utilities infrastructure, aerospace/defense and medical sectors.

Key Points: 
  • Emerald EMS is a high-tech contract manufacturing and design firm with global, cost-effective, and high value manufacturing solutions servicing high-reliability end users in the industrial controls, semiconductor, utilities infrastructure, aerospace/defense and medical sectors.
  • Vic Giglio, President of DataED, will serve as CEO of Emerald EMS, and Nat Mani, CEO of Bestronics, will serve as President of the new company.
  • As a result, Emerald EMS will offer our customers expanded capabilities, increased geographic flexibility, and complete product life-cycle supportfrom concept, through design and manufacturing, to maintenance and phase-out."
  • DataED and Bestronics joined New Water Capital's portfolio of companies with recapitalizations of both companies in November 2019, as New Water pursued new strategic investments in the EMS sector.

Sparton Corporation Announces Sale of Its Manufacturing & Design Services Business to One Equity Partners

Retrieved on: 
Friday, June 26, 2020
Manufacturing, Defense, Other Defense, Engineering, Contracts, Manufacturing, Contract manufacturer, Outsourcing, Sparton Corporation, One Equity Partners

Sparton Corporation (Sparton), a leading provider of engineered products for the defense industry, today announced that it has entered into a definitive agreement to sell its contract manufacturing unit, Manufacturing & Design Services (MDS), to One Equity Partners (OEP), a middle market private equity firm.

Key Points: 
  • Sparton Corporation (Sparton), a leading provider of engineered products for the defense industry, today announced that it has entered into a definitive agreement to sell its contract manufacturing unit, Manufacturing & Design Services (MDS), to One Equity Partners (OEP), a middle market private equity firm.
  • Now, these leading platforms will be able to focus on their respective core strengths and capitalize on opportunities specific to each business.
  • Sparton, now in its 120th year, is a provider of engineered products for the defense industry and complex contract manufacturing solutions.
  • Spartons Manufacturing & Design Services business provides complex, sophisticated electromechanical solutions for a range of industries.

Global Personal Care Contract Manufacturing Market Trends Analysis Report 2020-2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 12, 2020
Cosmetics, Retail, Contract manufacturer, Manufacturing, Outsourcing, Disposable product, Hygiene, Articles, Euthenics, Humans

gThe "Personal Care Contract Manufacturing Market Size, Share & Trends Analysis Report by Service (Manufacturing, Packaging), by Region (APAC, North America, Europe, RoW), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • gThe "Personal Care Contract Manufacturing Market Size, Share & Trends Analysis Report by Service (Manufacturing, Packaging), by Region (APAC, North America, Europe, RoW), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global personal care contract manufacturing market size is expected to reach USD 29.2 billion by 2027, registering a CAGR of 6.1% over the forecast period according to this report.
  • Rising demand for organic products due to increased awareness of harmful effects of chemical-based products is likely to boost the market growth.
  • Increasing disposable income coupled with rising consumer awareness on personal hygiene, is expected to drive the market.

Global Pharmaceutical Contract Manufacturing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Retrieved on: 
Thursday, June 4, 2020
Health, Pharmaceutical industry, Articles, Pharmacology, Pharmacy, Pharmaceutical manufacturing, Manufacturing, Contract manufacturer, Pharmaceutical industry in China, Dr. Reddy's Laboratories

On the basis of Type of Contract Manufacturing, the Global Pharmaceutical Contract Manufacturing Market is studied across API or Bulk Drug Manufacturing and Final Dosage Form.

Key Points: 
  • On the basis of Type of Contract Manufacturing, the Global Pharmaceutical Contract Manufacturing Market is studied across API or Bulk Drug Manufacturing and Final Dosage Form.
  • What are the factors that affect the growth in the Global Pharmaceutical Contract Manufacturing Market over the forecast period?
  • Which are the best product areas to be invested in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
  • What are the modes of entering the Global Pharmaceutical Contract Manufacturing Market?

Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030

Retrieved on: 
Tuesday, May 12, 2020
Contract manufacturing organization, Pharmaceutical industry, Contract manufacturer, Fine chemical

Presently, there are a number of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that offer elaborate portfolios of services focused on peptide design, manufacturing and purification.

Key Points: 
  • Presently, there are a number of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that offer elaborate portfolios of services focused on peptide design, manufacturing and purification.
  • The "Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030" report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.
  • Elaborate profiles of the key players that offer contract manufacturing services across different geographies, namely North America, Europe and Asia Pacific.
  • One of the key objectives of the report was to estimate the existing market size and the future growth potential within the peptide contract manufacturing market.

Insights on the Worldwide Biopharmaceutical Contract Manufacturing Industry to 2027 - Analysis and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 29, 2020
Biotechnology, Pharmaceutical, Health, Articles, Business, Life sciences, Pharmaceutical industry, Pharmacy, Biotechnology, Pharmaceuticals policy, Biopharmaceutical, Pharmaceutical industry in India, Contract manufacturing organization, Pharmaceutical industry in China, Contract manufacturer

The "Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product; Service, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product; Service, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • Driving factors of the biopharmaceuticals contract manufacturing market are increasing trend of outsourcing among pharmaceuticals companies and elevating demand for biologics.
  • However, growing competition in biopharmaceutical contract manufacturing industry is hindering the growth of the market.
  • The contract manufacturing organization (CMO) offers numerous benefits, including reducing investments in facilities and drug development costs, to pharmaceutical companies, thereby improving net cash flow.

Biologic Drug Product CM Quality Benchmarking Report 2020: A Look at Small & Emerging Biopharma - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 28, 2020
Health, Pharmaceutical, Articles, Business, Economy, B2B, Contract manufacturer, Manufacturing, CMO, Benchmarking, Outsourcing

The "Biologic Drug Product Contract Manufacturer Quality Benchmarking: A Look at Small & Emerging Biopharma" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biologic Drug Product Contract Manufacturer Quality Benchmarking: A Look at Small & Emerging Biopharma" report has been added to ResearchAndMarkets.com's offering.
  • This report is an-depth look at a subset of respondents from small and emerging biopharma companies.
  • The findings in this report will help small and emerging biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.
  • The report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing philosophies and practices, CMO selection drivers, and CMO perceptions and interactions.

PharmSource: Contract Manufacturing of Novel In-Licensed Drugs 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 14, 2020
Health, Pharmaceutical, Articles, Business, Economy, Supply chain management, Contract manufacturing organization, Pharmaceutical industry, Contract manufacturer, Outsourcing, Food and Drug Administration, Procurement

The "PharmSource: Contract Manufacturing of Novel In-Licensed Drugs - 2020 Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "PharmSource: Contract Manufacturing of Novel In-Licensed Drugs - 2020 Edition" report has been added to ResearchAndMarkets.com's offering.
  • This expert trend report explores in-licensing trends among FDA New Molecule Entity (NME) approvals 2014-2018, and analyzes how licensing patterns affect the propensity to outsource finished dose manufacture.
  • This report is critical for establishing an understanding of the ways bio/pharmaceutical companies source their drugs, and the factors that make them more likely to engage a contract manufacturing organization (CMO).
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.